Lifestyle training for schizophrenia: STEPWISE fails to make a difference

clem-onojeghuo-1169553-unsplash

Ben Janaway writes his debut elf blog on the STEPWISE RCT which is out today in the British Journal of Psychiatry: Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis.

[read the full story...]

A psychological victory for the domestic violence and abuse sector: the PATH trial

Young adults who reported depressive and/or suicidality symptoms in adolescence were significantly more likely to have experienced relationship violence in their romantic relationships

Emma Yapp summarises two new studies out yesterday looking at the PATH intervention (Psychological Advocacy Towards Healing), a CBT-informed psychological intervention delivered by trained domestic violence and abuse (DVA) advocates in specialist services.

[read the full story...]

Transdiagnostic and disorder-specific anxiety disorder treatments have equivalent treatment effects #TransDX2018

pawel-czerwinski-716699-unsplash

Jill Newby and Peter Norton blog an RCT on the unified protocol for transdiagnostic treatment of emotional disorders compared with diagnosis-specific protocols for anxiety disorders.

[read the full story...]

Preventive cognitive therapy when continuing or tapering off antidepressants

thomas-jorn-461490-unsplash

Linda Gask is encouraged by the findings of a new high quality RCT (the DRD study), which compares preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in the prevention of depressive relapse or recurrence.

[read the full story...]

Is Cannabidiol (CBD) an effective antipsychotic?

24281909498_a080b71a94_k

Luke Sheridan Rains publishes his debut blog on a recent multicentre RCT of Cannabidiol (CBD) as an adjunctive therapy for people with schizophrenia, which suggests that CBD had a beneficial, but modest impact on positive psychotic symptoms and severity of illness when used alongside existing antipsychotics.

[read the full story...]

Collaborative care for depression and physical multimorbidity: clinically and cost-effective over the long term

rawpixel-587848-unsplash

Gemma Shields summarises the findings of a cluster RCT looking at the long-term clinical and cost-effectiveness of collaborative care (versus usual care) for people with mental-physical multimorbidity.

[read the full story...]

Low dose Amisulpride for very late onset schizophrenia-like psychosis: the ATLAS study

kiwihug-393309-unsplash

Elwira Lubos summarises the recent ATLAS RCT of antipsychotic treatment for very late-onset schizophrenia-like psychosis, which provides evidence for the effectiveness of a very low dose of Amisulpride (100 mg).

[read the full story...]

After the crisis: self-management and peer-support

daniel-jensen-440210-unsplash (1)

Jenny Collom, Maria Giorgalli and Derek Tracy welcome a new RCT published yesterday in The Lancet which demonstrates the benefits of peer-supported self-management for people discharged from a mental health crisis team.

[read the full story...]

Incredible Years Teacher Classroom Management: STARS trial suggests benefits for children’s mental health

rawpixel-660721-unsplash (1)

Neil Humphrey is impressed by the STARS cluster randomised controlled trial published today in Psychological Medicine, which evaluates the effectiveness and cost-effectiveness of the Incredible Years Teacher Classroom Management programme in primary school children.

[read the full story...]

QbTest is not a diagnostic tool, but it can increase the efficiency of ADHD diagnosis

Qbtest-square

Samuele Cortese is impressed by a recent RCT of QbTest: a computerised test of attention and activity, which can improve diagnostic decision-making in children and young people with suspected ADHD.

[read the full story...]